ImpediMed Limited
IPDQFOTCHealthcare● Active
$0.00
$-0.00(-23.73%)
Market Cap$10527165
P/E Ratio—
52W High$0.0514
52W Low$0.0045
ImpediMed Limited (IPDQF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · IPDQF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-06 | 2024-06 | 2023-06 | 2022-06 | 2021-06 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $12.72M | $10.05M | $11.34M | $10.49M | $8.35M |
| Cost of Revenue | $1.75M | $1.31M | $25.00M | $1.71M | $1.60M |
| Gross Profit | $10.97M | $8.74M | ($13.65M) | $8.79M | $6.75M |
| Gross Margin %(computed) | 86.25% | 86.93% | -120.36% | 83.72% | 80.82% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.22M | $0.60M | $0.68M | $1.46M |
| G&A Expenses | $21.51M | $22.09M | $19.51M | $18.15M | $21.42M |
| Total Operating Expenses | $35.21M | $33.04M | $9.19M | $30.32M | $29.82M |
| Operating Income | ($24.23M) | ($24.30M) | ($22.85M) | ($21.54M) | ($23.07M) |
| Operating Margin %(computed) | -190.44% | -241.76% | -201.39% | -205.21% | -276.22% |
| Interest Income | $0.96M | $1.56M | $0.80M | $0.05M | $0.02M |
| Interest Expense | $1.09M | $0.09M | $0.03M | $0.03M | $0.05M |
| Income Before Tax | ($23.21M) | ($19.76M) | ($22.08M) | ($19.83M) | ($20.67M) |
| Income Tax Expense | $0.03M | $0.03M | ($1.55M) | $0.05M | $0.04M |
| Net Income | ($23.24M) | ($19.79M) | ($20.52M) | ($19.87M) | ($20.71M) |
| Net Margin %(computed) | -182.62% | -196.86% | -180.90% | -189.37% | -247.89% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.01 | $-0.01 | $-0.01 | $-0.01 | $-0.02 |
| Wtd Avg Shares | 2019.18M | 2021.74M | 1800.35M | 1678.95M | 1202.32M |
| EBITDA | ($17.55M) | ($22.05M) | ($20.49M) | ($18.77M) | ($21.37M) |
| EBITDA Margin %(computed) | -137.95% | -219.35% | -180.65% | -178.83% | -255.87% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · AUD · M
Explore more ImpediMed Limited data
About ImpediMed Limited (IPDQF) Income Statement
ImpediMed Limited (IPDQF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, IPDQF reported revenue of $0.01B, gross profit of $0.01B (gross margin 86.25%), and net income of ($0.02B) — a net profit margin of -182.62%.
Frequently asked questions
IPDQF · 4 questionsImpediMed Limited (IPDQF) reported revenue of $0.01B for 2025, up 26.6% year-over-year.
IPDQF revenueIPDQF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09